The predictive accuracy of multiparametric MRI at T3 during neoadjuvant chemotherapy
The authors aim to examine the predictive value of parameters derived from diffusion-weighted imaging and contrast-enhanced-MRI at various time-points during neoadjuvant chemotherapy in breast cancer
• Mid-therapy diameter changes are the best predictors of pCR in neoadjuvant chemotherapy.
• Volumetric measures are not strictly superior in therapy monitoring to lesion diameter.
• Size measures perform as a better predictor than ADC values
Article: Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
Authors: Lenka Minarikova, Wolfgang Bogner, Katja Pinker et al.